Cash from Operations (Quarterly) Chart

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
September 30, 2026 -10.08M
June 30, 2026 -29.00M
March 31, 2026 -10.94M
December 31, 2025 -1.076M
September 30, 2025 -9.024M
June 30, 2025 -3.415M
March 31, 2025 -8.172M
December 31, 2024 -9.028M
September 30, 2024 -7.527M
June 30, 2024 -9.99M
March 31, 2024 -9.784M
December 31, 2023 -10.96M
September 30, 2023 -7.799M
June 30, 2023 -10.37M
March 31, 2023 -10.83M
December 31, 2022 -10.51M
September 30, 2022 -6.871M
June 30, 2022 -12.85M
Date Value
March 31, 2022 -11.57M
December 31, 2021 -10.65M
September 30, 2021 -6.627M
June 30, 2021 -9.77M
March 31, 2021 -11.80M
December 31, 2020 -6.999M
September 30, 2020 -7.687M
June 30, 2020 -6.864M
March 31, 2020 -10.94M
December 31, 2019 -6.438M
September 30, 2019 -9.208M
June 30, 2019 -6.676M
March 31, 2019 -8.475M
December 31, 2018 -3.898M
September 30, 2018 -6.298M
June 30, 2018 -6.456M
March 31, 2018 -9.759M
December 31, 2017 -1.896M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Cypherpunk Technologies, Inc. -2.902M
Yarrow Bioscience, Inc. -89.96M
Faeth Therapeutics, Inc. -13.00M
Indaptus Therapeutics, Inc. -1.245M
Pyxis Oncology, Inc. -16.29M